General Information


DRACP ID  DRACP03615

Peptide Name  

Sequence  GXRKXHKXWAK,GXRKXHKXWA

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation,Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C86H122N32O9

Absent amino acids  CDEFILMNPQSTVY

Common amino acids  X

Mass  278287

Pl  12.57

Basic residues  9

Acidic residues  0

Hydrophobic residues  4

Net charge  9

Boman Index  -5675

Hydrophobicity  -154.09

Aliphatic Index  9.09

Half Life 
  /

Extinction Coefficient cystines  11000

Absorbance 280nm  523.81

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 19432402

Title  Antimicrobial action of prototypic amphipathic cationic decapeptides and their branched dimers

Doi Not available

Year  2009

Literature 2

Pubmed ID 20176897

Title  Synergy with rifampin and kanamycin enhances potency, kill kinetics, and selectivity of de novo-designed antimicrobial peptides

Doi Not available

Year  2010

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  8520

DRACP is developed by Dr.Zheng's team.